Device
Charge-Balanced, Symmetric Nerve Stimulation
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Other(2)
Detailed Status
unknown2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
unknown2100%
Recent Activity
0 active trials
Showing 2 of 2
unknownnot_applicable
Study of Application of Transcutaneous Trigeminal Nerve Stimulation on Autism Spectrum Disorder
NCT06233279
unknownnot_applicable
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348
Clinical Trials (2)
Showing 2 of 2 trials
NCT06233279Not Applicable
Study of Application of Transcutaneous Trigeminal Nerve Stimulation on Autism Spectrum Disorder
NCT06120348Not Applicable
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2